419.35↑3.00 (0.72%)
12:00 AM,29th Sep 2023419.35↑4.45 (1.07%)
12:00 AM,29th Sep 2023BSE : 507789
NSE : JAGSNPHARM
Sector : Health care
ISIN Code : INE048B01027
Last Updated: Sep 29 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 1098 |
Turnover (₹ Cr) | 0.05 |
Volume (Shares) | 11970 |
Face Value | 5 |
52-WK High | 514.85 |
52-WK High Date | 31 Jul 2023 |
52-WK Low | 285.00 |
52-WK Low Date | 27 Mar 2023 |
All Time High | 514.85 |
All Time High Date | 31 Jul 2023 |
All Time Low | 6.00 |
All Time Low Date | 27 Oct 2008 |
Promoted by J S Kochhar in 1978 Jagsonpal Pharmaceuticals is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary Jagsonpal Exports India Pvt Ltd.The company has a strategic alliance with Fidia Spa Italy; and B Spofola Czechoslovakia; to manufacture sophisticated drugs in India. It has tied up with another Israel-based company Makhteshim Chemical Works for acquiring the marketing rights of an anti-oxidant product. In 1994 the company has also promoted Aresco Financial Services a new financial company.The Company's R&D activities have resulted in manufacturing process upgradation improving packaging and cost containment. It's R&D activities are geared towards development of new product technologies which can be commercialised in future.It has tied up with Lycored Natural Products Industries (LNP) of Israel to launch a completely natural Lycopene bioactive product Lycored in India and SouthEast Asia.In the fiscal 2001 the company's sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds such as sluggish market trends lower growth rate of the industry and severe competition from drug majors. However the company has introduced various measures to counter the above factors so as to achieve continued growth and opportunity.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 1098 |
EPS - TTM (₹) [S] | 11.94 |
P/E Ratio (X) [S] | 6.91 |
Face Value (₹) | 5 |
Latest Dividend (%) | 100.00 |
Latest Dividend Date | 21 Aug 2023 |
Dividend Yield (%) | 1.19 |
Book Value Share (₹) [S] | 60.65 |
P/B Ratio (₹) [S] | 6.91 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|---|---|---|
Motilal Oswal S&P BSE Healthcare ETF | 0.00 | 80 | 0.05 |
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 410.05 423.00 |
Week Low/High | 408.65 435.00 |
Month Low/High | 408.65 475.00 |
Year Low/High | 285.00 515.00 |
All time Low/High | 1.38 515.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 1.39% | 1.53% | -0.27 | -0.18% |
1 Month | -3.28% | -3.86% | 1.16 | 1.53% |
3 Month | 13.05% | 13.17% | 2.99 | 3.51% |
6 Month | 40.91% | 41.08% | 14.26 | 15.85% |
1 Year | 15.21% | 15.03% | 16.70 | 16.77% |
3 Year | 1018.27% | 1013.81% | 73.35 | 74.99% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
25-02-2022 | J & P INVESTMENTS PARTNERSHIP | NSE | SELL | 225737 | 239.32 |
25-02-2022 | MANISH MAHESH GUPTA | NSE | BUY | 225067 | 239.32 |
22-02-2022 | NK SECURITIES RESEARCH PRIVATE LIMITED | NSE | BUY | 187783 | 231.51 |
22-02-2022 | NK SECURITIES RESEARCH PRIVATE LIMITED | NSE | SELL | 187911 | 231.63 |
22-02-2022 | RAJASTHAN GLOBAL SECURITIES PVT LTD | NSE | SELL | 140000 | 245.06 |
22-02-2022 | RAJASTHAN GLOBAL SECURITIES PVT LTD | NSE | BUY | 440659 | 228.00 |
22-02-2022 | XTX MARKETS LLP | NSE | BUY | 142145 | 231.33 |
22-02-2022 | XTX MARKETS LLP | NSE | SELL | 137115 | 231.75 |
21-02-2022 | GRAVITON RESEARCH CAPITAL LLP | NSE | BUY | 175873 | 215.53 |
21-02-2022 | GRAVITON RESEARCH CAPITAL LLP | NSE | SELL | 175873 | 215.37 |
Load More |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 68.72 |
Financial Institutions Banks | 0.00 |
Foreign Institutional Investors | 0.37 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 0.00 |
Other Institutional Investors | 0.83 |
Indian Public | 22.84 |
Others Non Institutional Investors | 7.24 |
Custodians | 0.00 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Managing Director : Manish Gupta
Addtnl Non-Executive Director : Harsha Raghavan
Independent Director : Debasis Bikash Nandy
Addtnl Independent Director : Radhika C Pereira
Addtnl Independent Director : Pallavi Dinodia
Addtnl Non-Executive Director : Prithipal Singh Kochhar
Company Sec. & Compli. Officer : Abhishek Joshi
Registered Office: T-210 J, Shahpur Jat,New Delhi,New Delhi-110049 Ph: 91-011-46181100/46109900